RGNT

Regentis Biomaterials Ltd.

Price Chart

No historical data available

Latest Quote

$2.00

-0.06 (-2.91%)
Current Price
Previous Close $2.06
Open $2.10
Day High $2.10
Day Low $2.00
Volume 19,325
Fetched: 2026-08-29T22:18:23
Stock Information
Shares Outstanding 7.02M
Total Debt $1.20M
Cash Equivalents $7.38M
Net Income $-13.69M
Sector Healthcare
Industry Medical Instruments & Supplies
Market Cap $14.05M
EPS (TTM) $-23.46
Exchange ASE
🌐 Visit Website
Recent Price History
No history data available. Data will be fetched automatically.
About Regentis Biomaterials Ltd.

Regentis Biomaterials Ltd., a regenerative medicine company, develops and commercializes tissue repair solutions in the United States. It offers Gelrin, a platform based on hydrogel matrix of polyethylene glycol diacrylate and denatured fibrinogen for the treatment and regeneration of damaged or diseased tissue; and GelrinC, a cell-free and off-the-shelf hydrogel, which is in Phase II clinical trial for the treatment of cartilage injuries in the knee. The company was incorporated in 2004 and is based in Herzliya, Israel.

📰 Latest News
No news articles available at the moment. Check back later for updates on RGNT.
Period:
Loading...
Income Statement (Annual)
Metric 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Revenue
Total Revenue $0 $0 $0 $0
Operating Revenue $0 $0 $0 $0
Expenses
Interest Expense $324,000 $171,000 $173,000 $0
Total Expenses $8,619,000 $-932,000 $1,931,000 $1,407,000
Rent Expense Supplemental $67,000 $69,000 $66,000 $84,000
Other Income Expense $231,000 $559,000 $-6,000 $357,000
Net Non Operating Interest Income Expense $-5,260,000 $3,310,000 $-2,195,000 $-399,000
Total Other Finance Cost $4,936,000 $-3,481,000 $2,022,000 $399,000
Interest Expense Non Operating $324,000 $171,000 $173,000 $0
Operating Expense $8,619,000 $-932,000 $1,931,000 $1,407,000
General And Administrative Expense $8,288,000 $712,000 $1,125,000 $436,000
Other Non Operating Income Expenses - $3,483,000 $-2,019,000 $-397,000
Income & Earnings
Net Income From Continuing Operation Net Minority Interest $-13,648,000 $4,801,000 $-4,132,000 $-1,449,000
Net Interest Income $-5,260,000 $3,310,000 $-2,195,000 $-399,000
Normalized Income $-13,879,000 $4,370,570 $-4,126,000 $-1,806,000
Net Income From Continuing And Discontinued Operation $-13,648,000 $4,801,000 $-4,132,000 $-1,449,000
Total Operating Income As Reported $-6,968,000 $932,000 $-1,931,000 $-1,407,000
Net Income Common Stockholders $-13,692,000 $4,753,000 $-4,180,000 $-1,497,000
Net Income $-13,648,000 $4,801,000 $-4,132,000 $-1,449,000
Net Income Including Noncontrolling Interests $-13,648,000 $4,801,000 $-4,132,000 $-1,449,000
Net Income Continuous Operations $-13,648,000 $4,801,000 $-4,132,000 $-1,449,000
Pretax Income $-13,648,000 $4,801,000 $-4,132,000 $-1,449,000
Operating Income $-8,619,000 $932,000 $-1,931,000 $-1,407,000
Per Share
Diluted EPS - $0.92 $-0.81 $-0.29
Basic EPS - $0.92 $-0.81 $-0.29
Other
Tax Effect Of Unusual Items $0 $128,570 $0 $0
Tax Rate For Calcs $0 $0 $0 $0
Normalized EBITDA (Bullshit earnings) $-13,555,000 $4,413,000 $-3,953,000 $-1,806,000
Total Unusual Items $231,000 $559,000 $-6,000 $357,000
Total Unusual Items Excluding Goodwill $231,000 $559,000 $-6,000 $357,000
EBITDA (Bullshit earnings) $-13,324,000 $4,972,000 $-3,959,000 $-1,449,000
EBIT $-13,324,000 $4,972,000 $-3,959,000 $-1,449,000
Diluted NI Availto Com Stockholders $-13,692,000 $4,753,000 $-4,180,000 $-1,497,000
Otherunder Preferred Stock Dividend $44,000 $48,000 $48,000 $48,000
Gain On Sale Of Security $231,000 $559,000 $-6,000 $357,000
Research And Development $331,000 $-1,644,000 $806,000 $971,000
Selling General And Administration $8,288,000 $712,000 $1,125,000 $436,000
Other Gand A $667,000 $643,000 $1,059,000 $352,000
Rent And Landing Fees $67,000 $69,000 $66,000 $84,000
Salaries And Wages $7,554,000 $0 $0 -
Diluted Average Shares - $5,179,378 $5,179,378 $5,179,378
Basic Average Shares - $5,179,378 $5,179,378 $5,179,378
Fetched: 2026-08-29
Balance Sheet (Annual)
Metric 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Assets
Net Tangible Assets $4,744,000 $-41,104,000 $-45,905,000 $-42,061,000
Total Assets $7,618,000 $482,000 $360,000 $1,717,000
Total Non Current Assets $0 $0 $0 $0
Current Assets $7,618,000 $482,000 $360,000 $1,717,000
Prepaid Assets $10,000 $180,000 $7,000 $451,000
Receivables $230,000 $73,000 $8,000 $26,000
Other Receivables $230,000 $73,000 $8,000 $26,000
Cash Cash Equivalents And Short Term Investments $7,378,000 $229,000 $345,000 $1,240,000
Cash And Cash Equivalents $7,378,000 $229,000 $345,000 $1,240,000
Debt
Total Debt $1,197,000 $4,945,000 $7,615,000 $6,472,000
Current Debt And Capital Lease Obligation $1,197,000 $4,945,000 $210,000 -
Current Debt $1,197,000 $4,945,000 $210,000 -
Other Current Borrowings $1,197,000 $4,945,000 $210,000 -
Net Debt - $4,716,000 $7,270,000 $5,232,000
Long Term Debt And Capital Lease Obligation - - $7,405,000 $6,472,000
Long Term Debt - - $7,405,000 $6,472,000
Liabilities
Total Liabilities Net Minority Interest $2,874,000 $41,586,000 $46,265,000 $43,778,000
Total Non Current Liabilities Net Minority Interest $0 $35,098,000 $43,126,000 $41,169,000
Current Liabilities $2,874,000 $6,488,000 $3,139,000 $2,609,000
Payables And Accrued Expenses $1,659,000 $1,379,000 $872,000 $626,000
Payables $266,000 $252,000 $354,000 $208,000
Accounts Payable $266,000 $252,000 $353,000 $206,000
Derivative Product Liabilities - $0 $623,000 $685,000
Other Current Liabilities - $160,000 - -
Current Deferred Liabilities - $0 $2,054,000 $1,981,000
Other Payable - - $1,000 $2,000
Equity
Common Stock Equity $4,744,000 $-41,104,000 $-45,905,000 $-42,061,000
Total Equity Gross Minority Interest $4,744,000 $-41,104,000 $-45,905,000 $-42,061,000
Stockholders Equity $4,744,000 $-41,104,000 $-45,905,000 $-42,061,000
Retained Earnings $-55,794,000 $-42,146,000 $-46,947,000 $-42,815,000
Preferred Securities Outside Stock Equity $0 $35,098,000 $35,098,000 $34,012,000
Other
Ordinary Shares Number $5,179,378 $5,179,378 $4,929,378 $4,929,378
Share Issued $5,179,378 $5,179,378 $4,929,378 $4,929,378
Tangible Book Value $4,744,000 $-41,104,000 $-45,905,000 $-42,061,000
Invested Capital $5,941,000 $-36,159,000 $-38,290,000 $-35,589,000
Working Capital $4,744,000 $-6,006,000 $-2,779,000 $-892,000
Total Capitalization $4,744,000 $-41,104,000 $-38,500,000 $-35,589,000
Additional Paid In Capital $60,538,000 $1,042,000 $1,042,000 $754,000
Capital Stock $0 $0 $0 $0
Common Stock $0 $0 $0 $0
Pensionand Other Post Retirement Benefit Plans Current $18,000 $4,000 $3,000 $2,000
Current Accrued Expenses $1,393,000 $1,127,000 $518,000 $418,000
Current Deferred Revenue - $0 $2,054,000 $1,981,000
Fetched: 2026-08-29
Cash Flow Statement (Annual)
Metric 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Free Cash Flow
Free Cash Flow $-1,375,000 $-641,000 $-1,220,000 $-1,504,000
Operating Activities
Operating Cash Flow $-1,375,000 $-641,000 $-1,220,000 $-1,504,000
Cash Flow From Continuing Operating Activities $-1,375,000 $-641,000 $-1,220,000 $-1,504,000
Operating Gains Losses $6,882,000 $-531,000 $11,000 $-329,000
Financing Activities
Issuance Of Capital Stock $8,224,000 $0 $0 -
Financing Cash Flow $8,524,000 $525,000 $325,000 $0
Cash Flow From Continuing Financing Activities $8,524,000 $525,000 $325,000 $0
Net Common Stock Issuance $8,224,000 $0 $0 -
Common Stock Issuance $8,224,000 $0 $0 -
Other
Repayment Of Debt $0 $-325,000 $0 -
Issuance Of Debt $300,000 $850,000 $325,000 $0
End Cash Position $7,378,000 $229,000 $345,000 $1,240,000
Beginning Cash Position $229,000 $345,000 $1,240,000 $2,744,000
Changes In Cash $7,149,000 $-116,000 $-895,000 $-1,504,000
Net Issuance Payments Of Debt $300,000 $525,000 $325,000 $0
Net Short Term Debt Issuance $300,000 $75,000 $325,000 $0
Short Term Debt Payments $0 $-325,000 $0 -
Short Term Debt Issuance $300,000 $400,000 $325,000 $0
Net Long Term Debt Issuance $0 $450,000 $0 $0
Long Term Debt Issuance $0 $450,000 $0 $0
Change In Working Capital $131,000 $-1,599,000 $709,000 $-123,000
Change In Other Current Assets $-163,000 $-238,000 $462,000 $-106,000
Change In Payables And Accrued Expense $294,000 $-1,361,000 $247,000 $-17,000
Change In Payable $294,000 $-1,361,000 $247,000 $-17,000
Change In Account Payable $14,000 $-101,000 $147,000 $-102,000
Other Non Cash Items $5,260,000 $-3,312,000 $2,192,000 $397,000
Earnings Losses From Equity Investments $7,042,000 $0 - -
Gain Loss On Investment Securities $-160,000 $-463,000 $-62,000 $-100,000
Net Foreign Currency Exchange Gain Loss $0 $-68,000 $73,000 $-229,000
Net Income From Continuing Operations $-13,648,000 $4,801,000 $-4,132,000 $-1,449,000
Fetched: 2026-08-29